Tibolone and the Promise of Ideal Hormone-Replacement Therapy  

Oleh:

Fuleihan, Ghada El-Hajj

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 359 no. 07 (Aug. 2008), page 753.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Since the mean life expectancy at menopause is 32.7 years, women spend more than one third of their lives in the estrogen-deficient postmenopausal state.1 Of the majority of menopausal women who have climacteric symptoms, 20% describe them as intolerable, and one third have such symptoms for up to 5 years.2 During her lifetime, one of every two women will have an osteoporotic fracture, one third will have coronary heart disease, one fifth will have a stroke or Alzheimer's disease, and one eighth will have breast cancer. Whereas hormone-replacement therapy was once accepted as the ideal strategy for optimizing postmenopausal health . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali